Biomaterial Database

[Secretion of gastrin, pancreatic polypeptide and glucagon in persons with simple obesity]. 1987

M Szurkowski, and K Daniel, and F Kokot, and W Grzeszczak

UI	MeSH Term	Description	Entries
D008297	Male		Males
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D009765	Obesity	A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010191	Pancreatic Polypeptide	A 36-amino acid pancreatic hormone that is secreted mainly by endocrine cells found at the periphery of the ISLETS OF LANGERHANS and adjacent to cells containing SOMATOSTATIN and GLUCAGON. Pancreatic polypeptide (PP), when administered peripherally, can suppress gastric secretion, gastric emptying, pancreatic enzyme secretion, and appetite. A lack of pancreatic polypeptide (PP) has been associated with OBESITY in rats and mice.	Pancreatic Polypeptide (PP),Pancreatic Polypeptide Hormone,Pancreatic Prohormone
D004038	Diet, Reducing	A diet designed to cause an individual to lose weight.	Weight Loss Diet,Weight Reduction Diet,Diet, Weight Loss,Diet, Weight Reduction,Diets, Reducing,Diets, Weight Loss,Diets, Weight Reduction,Reducing Diet,Reducing Diets,Weight Loss Diets,Weight Reduction Diets
D005260	Female		Females
D005755	Gastrins	A family of gastrointestinal peptide hormones that excite the secretion of GASTRIC JUICE. They may also occur in the central nervous system where they are presumed to be neurotransmitters.	Gastrin
D005934	Glucagon	A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511)	Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults

Related Publications

M Szurkowski, and K Daniel, and F Kokot, and W Grzeszczak

[Effect of urapidil therapy on insulin, glucagon, gastrin and pancreatic polypeptide secretion in patients with idiopathic arterial hypertension].

January 1989, Polski tygodnik lekarski (Warsaw, Poland : 1960),

M Szurkowski, and K Daniel, and F Kokot, and W Grzeszczak

[Effect of propranolol therapy on the secretion of insulin, glucagon, gastrin and pancreatic polypeptide in patients with essential hypertension].

January 1989, Polskie Archiwum Medycyny Wewnetrznej,

M Szurkowski, and K Daniel, and F Kokot, and W Grzeszczak

Influence of long-term erythropoietin treatment on insulin, glucagon, pancreatic polypeptide, and gastrin secretion in haemodialysed patients.

January 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,

M Szurkowski, and K Daniel, and F Kokot, and W Grzeszczak

Influence of type of immunosuppressive therapy on gastrin, insulin, glucagon, and pancreatic polypeptide secretion in kidney transplant patients.

October 1987, Transplantation proceedings,

M Szurkowski, and K Daniel, and F Kokot, and W Grzeszczak

[Effect of long term prazosin treatment on secretion of insulin, glucagon, gastrin, and pancreatic polypeptide in patients with essential hypertension].

January 1993, Polskie Archiwum Medycyny Wewnetrznej,

M Szurkowski, and K Daniel, and F Kokot, and W Grzeszczak

Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity.

January 1983, International journal of obesity,

M Szurkowski, and K Daniel, and F Kokot, and W Grzeszczak

Glucagon and gastrin secretion by a pancreatic tumour and its metastases.

January 1982, Journal of the Royal Society of Medicine,